Centre-specific ultrasound nuchal translucency medians needed for Down syndrome screening

Prenatal Diagnosis

Volumn 23, Issue 5, 2003, Pages 389-392

  Logghe, H ^a   Cuckle, H ^b   Sehmi, I ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Audit; Between operators; Between centre differences; Multiples of the median; Nuchal translucency

Indexed keywords

ARTICLE; CLINICAL TRIAL; DISEASE MARKER; DOWN SYNDROME; FEMALE; FETUS ECHOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL SERUM; MATHEMATICAL ANALYSIS; MEASUREMENT; MULTICENTER STUDY; PRENATAL SCREENING; PRIORITY JOURNAL; REGRESSION ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; DOWN SYNDROME; FEMALE; HUMANS; MASS SCREENING; NECK; PREGNANCY; PREGNANCY TRIMESTER, FIRST; REFERENCE VALUES; ULTRASONOGRAPHY, PRENATAL;

EID: 0037903708     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.597     Document Type: Article

References (23)

1. Biagiotti R, Periti E, Brizzi L, Vanzi E, Cariati E. 1997. Comparison between two methods of standardization for gestational age differences in fetal nuchal translucency measurement in first-trimester screening for trisomy 21. Ultrasound Obstet Gynecol 9: 248-252.
2. Braithwaite JM, Economides DL. 1995. The measurement of nuchal translucency with transabdominal and transvaginal sonography - success rates, repeatability and levels of agreement. Br J Radiol 68: 720-723.
3. Cuckle H. 1996. Biochemical and ultrasound screening for Down's syndrome: rivals or partners'? Ultrasound Obstet Gynecol 7: 236-238.
4. Cuckle H, Sehmi IK. 1999. Calculating correct Down's syndrome risks. Br J Obstet Gynaecol 106: 371, 372.
5. Cuckle H. 2001. Integrating Down's syndrome screening. Curr Opin Obstet Gynaecol 13: 175-181.
6. de Graaf IM, Pajkrt E, Bilardo CM, Leschot NJ, Cuckle HS, Van Lith JMM. 1999. Early pregnancy screening for fetal aneuploidy with serum markers and nuchal translucency. Prenat Diagn 19: 458-462.
7. Gasiorek-Wiens A, Tercanli S, Kozlowski P, et al. 2001. Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland. Ultrasound Obstet Gynecol 18: 645-648.
8. Jou HJ, Wu SC, Li TC, Tzeng CY, Hsu HC, Hsieh FJ. 2001. Relationship between fetal nuchal translucency and crown-rump length in an Asian population. Ultrasound Obstet Gynecol 17: 111-114.
9. Krantz DA, Hallahan TW, Orlando F, Buchanan P, Larsen JW, Macri JN. 2000. First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucency. Obstet Gynecol 96: 207-213.
10. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. 1992. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 304: 867-869.
11. Nicolaides KH, Snijders RJM, Cuckle HS. 1999. Correct estimation of parameters for ultrasound nuchal translucency screening. Prenat Diagn 18: 519-521.
12. Office of Population Censuses and Surveys. 1996-2000. Birth Stat Ser FM1: 23-27.
13. Pajkrt E, van Lith JMM, Mol BW, Bleker OP, Bilardo CM. 1998. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population. Ultrasound Obstet Gynecol 12: 163-169.
14. Pandya PP, Altman DG, Brizot ML, Pettersen H, Nicolaides KH. 1995. Repeatability of measurement of fetal nuchal translucency thickness. Ultrasound Obstet Gynecol 5: 334-337.
15. Robinson HP, Fleming JEE. 1975. A critical evaluation of sonar crown-rump length measurement by ultrasound in normal pregnancy. Br J Obstet Gynaecol 82: 702-710.
16. Schuchter K, Wald N, Hackshaw AK, Hafner E, Liebhart E. 1998. The distribution of nuchal translucency at 10-13 weeks of pregnancy. Prenat Diagn 18: 281-286.
17. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 352: 343-346.
18. Snijders RJ, Thom EA, Zachary JM, et al. 2002. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultrasound Obstet Gynecol 19: 353-359.
19. Spencer K, Spencer CE, Power M, Moakes A, Nicolaides KH. 2000. One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. Br J Obstet Gynaecol 107: 1271-1275.
20. Thilaganathan B, Khare M, Williams B, Wathen NC. 1998. Influence of ethnic origin on nuchal translucency screening for Down's syndrome. Ultrasound Obstet Gynecol 12: 112-114.
21. Wøjdemann KR, Christiansen M, Sundberg K, Larsen SO, Shalmi A, Tabor A. 2001. Ultrasound Obstet Gynecol 18: 641-644.
22. Yagel S, Anteby EY, Rosen L, Yaffe E, Rabinowitz R, Tadmor O. 1998. Assessment of first-trimester nuchal translucency by daily reference intervals. Ultrasound Obstet Gynecol 11: 262-265.
23. Zoppi MA, Ibba RM, Floris M, Monni G. 2001. Fetal nuchal translucency screening in 12,495 pregnancies in Sardinia. Ultrasound Obstet Gynecol 18: 649-651.